£15bn company GE Healthcare announced the opening of a biotechnology manufacturing center in Stevenage, to improve the purification steps of manufacturing biopharmaceuticals.
In the first half of 2019, the center will start producing a fiber-based purification platform – image courtesy of Depositphotos. In the first half of 2019, the center will start producing a fiber-based purification platform, which has the potential to significantly improve efficiency in the purification steps of manufacturing biopharmaceuticals, gene…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
